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CAVOY, A., A. ENNACEUR AND J. DELACOUR. Effects ofpiracetam on learned helplessness in rats. PHYSIOL 
BEHAV 42(6) 545-549, 1988.--In rats, the effects of Piracetam (P), the prototype of nootropic drugs, were studied on a 
very widely used model of behavioral disturbance: the learned helplessness (LH) phenomenon. In this model, exposure to 
uncontrollable and unsignalled shocks impairs subsequent escape-avoidance learning. In a first experiment, this deficit was 
abolished by 200 mg/kg of P, and to a lesser extent, by a 100 mg/kg dose, administered before the training session. In 
non-stressed animals, no dose of P was able to have a facilitatory effect on escape-avoidance. In a second experiment, the 
administration of P, not before the training session as in Experiment I, but before the stress, had no effect on the LH 
phenomenon regardless of the dose. 
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FACILITATORY effects of nootropic drugs on learning, 
memory and other cognitive processes [7,8], while fre- 
quently reported,  remain controversial.  
Most of  these effects were observed in deficient or- 
ganisms. Nootropic drugs improve learning and memory per- 
formances in aged animals [2,25] and in animals subjected to 
hypoxia,  hypercapnia,  electroconvulsive shocks, ischemia, 
amnestics drugs such as scopolamine and antibiotics [3, 6, 
14, 21]; similar effects were observed in senile humans and in 
patients suffering from brain pathologies [9, 11, 13, 16, 19, 
20, 24]. 
These data raise an important question: is this normalizing 
action restricted to the effects of purely organic deficiencies 
such as those mentioned above or does it also have a signifi- 
cant role in "funct ional"  disturbances produced in normal 
organisms by environmental factors. In the latter case, the 
field of  application of  nootropic drugs would be considerably 
increased since the second type of disturbance is at least as 
frequent as the first. So far, the only evidence supporting this 
point is the fact that "behavioral  dispair ,"  a behavioral test 
sensitive to anti-depressant drugs [18], is significantly re- 
duced in mice by nootropic administration [22]. 
We tried to obtain further information by the study of  the 
effects of  Piracetam (P), the prototype of  nootropic drugs, 
(Nootropil ,  2-oxo-l-pyrrolidine acetamide, a cyclic deriva- 
tive of  GABA),  on one of  the most popular  models of  behav- 
ioral disturbances: the " learned helplessness,"  LH [17]. In 
this model, exposure to uncontrollable and unsignalled 
shocks impairs subsequent escape-avoidance learning. 
Whatever  be the involvement of  cognitive factors in LH,  it is 
generally considered as a model of  depression. 
METHOD 
General Methods 
Animals were male Wistar rats weighing 250-300 g. They 
were housed in individual cages and maintained on a 12:12 
light-dark schedule (0700:1900 hours). Ambient temperature 
was 23°C-1.  Standard rodent food as well as water were 
available ad lib throughout the experiments.  
Behavioral tests were performed in shuttle-boxes which 
were 60x 30× 50 cm (height) Plexiglas cages divided into two 
compartments (30x30 cm) by a 5 cm barrier. The floor and 
the barrier were made of  brass bars, 4 mm in diameter and 15 
mm apart. The crossing of the barrier was detected by an 
infrared system. Each compartment  was equipped with a 15 
W bulb fastened to the end wall, 35 cm above the floor. The 
apparatus was placed in a sound-attenuated cabinet measur- 
ing approximately 1 m 3, in which sound-attenuation was 
aided by a masking noise of 70 dB above the human 
threshold. A 15 W bulb fastened to the ceiling of  the cabinet 
provided a constant illumination of 10 lux at the level of  the 
floor of  the shuttle-box. The programming and recording 
apparatus were located outside the cabinet and the animals 
were observed by means of a closed-circuit television. Four  
identical shuttle-boxes located in different cabinets permit- 
ted the simultaneous testing of  four animals. 
The animals were handled daily for at least a week prior 
to behavioral testing. 
Control (physiological saline) and experimental  
(Piracetam) injections were administered IP 30 min before 
sessions in the volume of  1 ml/kg. Piracetam (P) injections 
were prepared from a solution of  Gabacet  (Carrion, France) 
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TABLE 1 
RESULTS OF EXPERIMENT 1 
Groups NSP1 NSP2 NSP3 NSC SP1 SP2 SP3 SC 
CAR 16.3 17.4 14.6 16.8 4.3 7.9 12.6 4.8 
--_2.7 3.1 3.3 2.9 1.5 1.9 2.4 1.3 
Fr 2.6 2.1 3.1 2.4 7.1 3.8 1.6 11.1 
_-_0.9 0.6 1.0 0.9 2.1 1,6 0.8 4.4 
ITC 41.2 39.3 35.7 40.8 11.5 23.4 32.2 12.3 
_+10.4 11,0 8.9 11.2 5.9 10.1 9.8 6.1 
*Mean values -+ S.E.M. 
CAR: Conditioned Avoidance Responses, Fr: "Freezing," ITC: lntertrial Crossings, during 
session 2. 
diluted in an approximate volume of physiological saline. 
As the design of experiments was a 2x4 (Stress x Drug) 
factorial plan, two-way ANOVAs were computed according 
to Winer [26]. 
Experiment I 
Eighty rats were submitted to two sessions separated by a 
24 hr interval. During the first session, forty animals 
(stressed, S) were placed in the shuttle-boxes and subjected 
to 40 unsignalled and uncontrollable electrical shocks of 1 
mA and 10 sec in duration, separated by a mean interval of 
70 sec (range: 40--90). The other forty rats were placed for 
the same duration in the same apparatus and according to the 
same conditions but received no shocks (non stressed, NS). 
Before this session, all the animals received a control injec- 
tion. 
During session II, in the same apparatus, all the animals 
were submitted to an escape-avoidance conditioning. The 
session consisted of 40 trials separated by an interval of 70 
sec (range: 40--90). The signal was the simultaneous illumi- 
nation of the two bulbs fastened to the interior of the 
shuttle-box; intensity of this signal at floor level was 200 lux. 
Five seconds after the onset of the signal, an electric shock 
of I mA was delivered to the floor and the barrier by means 
of a scrambler-equipped generator. A complete crossing of 
the barrier during the signal-shock interval terminated the 
signal and no shock was delivered (conditioned avoidance 
response, CAR). A crossing made more than 5 sec after 
signal onset simultaneously ended the signal and the shock 
(escape response). Maximum shock duration was 10 sec. 
When no avoidance or escape response were made during a 
trial, the behavior of the rat was classified as "freezing" 
(Fr). Three measurements were considered: the numbers of 
CAR, Fr and intertrial crossings (ITC). The number of Fr 
may be considered as a global index of escape-avoidance 
behavior to which it was inversely related. 
Before escape-avoidance training, S (stressed) animals 
were randomly divided into four groups (n= 10), one receiv- 
ing a control injection (SC group), the other three, 50 nag, 100 
mg and 200 mg/kg of P (SP1, SP2 and SP3 groups respec- 
tively). In a parallel fashion, NS (non-stressed) rats were 
randomly divided into four groups (n=10): NSC, NSP1, 
NSP2 and NSP3 receiving respectively a control injection, 
50, 100 or 200 mg/kg of P before session II. 
Experiment H 
It was performed on another batch of animals in exactly 
the same conditions as Experiment I, except that the exper- 
imental injections to the appropriate groups were adminis- 
tered before session I instead of session II: Before session I, 
forty animals were randomly divided into four groups 
(n= 10), one receiving a control injection (CS group), the 
others, 50, 100 or 200 mg/kg of P (groups PIS, P2S and P3S 
respectively). After injection, these four groups were sub- 
mitted to uncontrollable and unsignalled shocks as in Exper- 
iment I. In a parallel fashion, forty other animals were di- 
vided into four groups: CNS, PINS, P2NS and P3NS. Each 
of these groups was subjected to the appropriate injection 
(saline, 50, 100 and 200 mg/kg of P respectively) and then 
placed in the shuttle-boxes where no shock was delivered. 
Before session II, a control injection (physiological 
saline) was administered to all the animals then they were 
submitted to an escape-avoidance training as in Experiment I. 
RESULTS 
Experiment I (Table 1) 
(1) Number of CAR. The factor Stress was significant, 
F(1,72)=10.71, p<0.01,  as well as the factor Drug, 
F(3,72) = 5.08, p <0.01, but not the interaction Stress x Drug, 
F(3,72)=2.17, p>0.05. The main results of the two by two 
comparisons were as follows. 
The SC group made significantly (p<0.01) less CAR than 
the NSC which means that the avoidance behavior in session 
II was impaired in the control animals stressed during ses- 
sion I. 
The SP3 group made significantly (p<0.05) more CAR 
than the SC and did not differ from the NSC. These two 
results show that the avoidance deficit produced by the 
stress was abolished by the 200 mg/kg dose of P. However, 
the 50 mg and 100 mg/kg doses were ineffective since the SP1 
and SP2 groups were significantly inferior (,o<0.05) to the 
NSC and did not differ from the SC. 
The NSP1, NSP2 and NSP3 groups were not significantly 
different from the NSC which means that in animals not 
previously stressed no dose of P was able to modify the 
acquisition of CAR. 
(2) Number of freezing. The factor Stress was significant, 
F(1,72)=8.39, p<0.01, as well as the factor Drug, 
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TABLE 2 
RESULTS OF EXPERIMENT 2 
Groups PINS P2NS P3NS CNS PIS P2S P3S CS 
CAR 15.1 12.7 13.2 14.5 4.2 4.6 4.0 3.8 
_+ 3.3 3.4 2.8 4.1 1.2 1.4 1.6 1.7 
Fr 3.4 3.9 2.7 3.7 12.3 7.2 13.2 14.0 
_+1.1 1.4 1.0 1.3 5.0 4.1 4.8 6.2 
ITC 47.6 51.3 44.2 49.8 27.7 15.4 18.5 17.9 
-+9.8 12.3 10.7 14.5 11.5 6.1 6.8 5.9 
CROS 52.8 49.4 57.6 55. l 75.4 69 80.2 71.6 
_+11.9 7.5 10.4 8.8 16.2 14.3 15.7 12.8 
*Mean values _+ S.E.M. 
CAR: Conditioned Avoidance Responses, Fr: 
session 2. CROS: Crossings during session 1. 
"Freezing," ITC: Intertrial Crossings, during 
F(3,72)-3.43,  p<0.02,  but not the Stress x Drug interaction, 
F(3,32)--2.47, p>0.05.  The results of  the two by two com- 
parisons were mainly the mirror image of  the preceding ones. 
The SC group made significantly more Fr  09<0.02) than 
the NSC: the stress in session I globally impaired the 
escape-avoidance behavior of  stressed controls in session II. 
The SP3 group made significantly less Fr  09<0.05) than 
the SC but did not differ from the NSC: the 200 mg/kg dose 
of  P abolished the escape-avoidance deficit in the stressed 
animals. However,  the 50 mg/kg dose was ineffective since 
the SP1 group made significantly 09<0.05) more Fr  than the 
NSC and was not different from the SC; the 100 mg dose had 
intermediate effects (the SP2 group was not significantly dif- 
ferent from the NSC and SC groups). 
The number of  F r  was not modified by P administration in 
non-stressed animals since the NSPI ,  NSP2 and NSP3 
groups were comparable to the NSC. 
(3) Intertrial crossings. The factor Stress was significant, 
F(1,72)--12.46, p<0.01,  as well as the factor Drug, 
F(3,72)--7.17, p<0.01,  but not the interaction Stress x Drug, 
F(3,72)=2.04, p>0.05.  The SC group made significantly less 
09<0.01) ITC than the NSC, which means that the deficit in 
escape-avoidance behavior in control stressed rats was 
associated with a reduction of  ITC. This reduction was an- 
tagonized by the 200 mg/kg dose of  P since the SP3 group 
made significantly 09<0.02) more ITC than the SC but did 
not differ significantly from the NSC. The 50 mg dose was 
ineffective (the SP1 group was inferior to NSC 09<0.02) and 
not different from the SC group) and the 100 mg dose had 
intermediate effects (the SP2 group was not significantly dif- 
ferent from the NSC and SC groups). 
As for avoidance and freezing, none of the three doses of 
P had a significant effect on ITC in non-stressed animals. 
Experiment H (Table 2) 
(1) Number  of  CAR. The stress factor is significant, 
F(1,71)=13.39, p<0.01:  As a whole, the stressed animals 
(groups CS, P1S, P2S and P3S) made less CAR than the non- 
stressed (groups CNS, P INS,  P2NS, and P3NS). The 
number of  CAR of  the control stressed (CS) group was signif- 
icantly inferior 09<0.01) to that of  the control non-stressed 
(CNS): as in Experiment I, the stress of session I impaired 
avoidance behavior during session II. 
On the other hand, the Drug factor, F(3,72)= 1.21, and the 
Stress x Drug interaction, F(3,72)=0.91, were not signifi- 
cant 09>0.05). There were no differences between the 
stressed groups, especially between the experimental groups 
(P1S, P2S and P3S) and their control group (CS). Thus, no 
dose of  P administered before the stress (session I) was able 
to improve subsequent avoidance behavior (session II). As 
in Experiment I, there was no difference between non- 
stressed groups, that is, no effect of  P. 
(2) Number  of Fr. The Stress factor, F(1,72)=7.97, 
p<0.01,  was significant: As a whole, the stressed animals 
(groups CS, P1S, P2S and P3S) made more Fr  than the non- 
stressed (groups CNS, PINS,  P2NS and P3NS). The number 
of Fr  of  the CS group was significantly higher 09<0.02) than 
that of  the CNS: as in Experiment I, escape-avoidance be- 
havior was globally impaired in control stressed animals. 
On the other hand, the Drug factor, F(3,72)=0.58, and the 
Stress x Drug interaction, F(3,72)--1.04, were not signifi- 
cant 09 >0.05). There were no significant differences between 
the stressed groups, especially between the experimental  
groups and the controls: thus the freezing behavior during 
session II (avoidance training) was not decreased by P ad- 
ministered before session I (stress). As in Experiment I, 
there were no differences between the non-stressed groups. 
(3) Number of ITC. The Stress factor was significant, 
F(1,72)=5.34, p<0.02.  As a whole, the stressed animals 
made less ITC than the non-stressed 09<0.05) and the 
number of  ITC in the CS group was significantly lower than 
in the CNS 09<0.05). 
On the other hand, the Drug factor, F(3,72) = 1.11, and the 
Stress × Drug interaction, F(3,72)--0.51, was not significant 
09>0.05). There was no difference between the stressed 
groups: no dose of  P administered before session I had an 
effect on ITC during session II. There was also no difference 
between the non-stressed groups. 
(4) Number  of  cros sings during session I. Since the exper- 
imental injections were administered before session I instead 
of  session II as in Experiment I, a fourth measurement was 
considered in the results of  Experiment II: the number of 
crossings during session I. The Stress factor, F(1,72)=5.31, 
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p<0.02, was significant. As a whole, the stressed animals 
made more crossings than the non-stressed (p<0.02) but the 
interpretation of this result is difficult since most of the 
crossings of the stressed animals were elicited by electrical 
shocks while the non-stressed made only spontaneous cross- 
ings. More important is the fact that the Drug factor was not 
significant, F(3,72)=0.69,p>0.05: this means that no dose of 
P was able to modify the motor activity either in stressed or 
in non-stressed animals. The Stress x Drug interaction also 
did not reach significance, F(3,72)=0.86, p>0.05. 
DISCUSSION 
Results of Experiment I show the following: 
(1) The procedure we used was able to produce a learned 
helplessness phenomenon as defined in the introduction, that is 
an impairment in escape-avoidance behavior: compared to 
non-stressed controls, stressed controls made less CAR and 
showed more freezing. 
(2) This deficit was abolished by a 200 mg/kg dose of P 
administered just before the escape-avoidance training and 
to a lesser extent, by a 100 mg/kg dose. 
(3) In non-stressed animals, no dose of P was able to have 
a facilitatory effect on avoidance conditioning, which con- 
firms the data from Ennaceur and Delacour [4]. 
In Experiment II, the learned helplessness phenomenon 
was still present as indicated by the differences between 
stressed and non-stressed controls. However, the adminis- 
tration of P, not before escape-avoidance training (session II) 
as in Experiment I, but before the stress (session I), had no 
effect on the LH phenomenon regardless of the dose. 
The facilitatory action of P on escape-avoidance behavior 
in stressed animals may have several causes. 
(1) It can be considered as a performance effect. P could, 
as amphetamine [10], facilitate escape-avoidance behavior 
by increasing locomotor activity and decreasing freezing. 
However, this interpretation is not supported by our data. P 
had no effect on the motor activity of either stressed or non- 
stressed rats (Experiment II, session I) nor on the number of 
intertrial crossings during avoidance conditioning in the 
non-stressed rats (Experiment I, session II). Stressed rats 
receiving 200 mg/kg of P made more ITC than stressed con- 
trols but did not differ from non-stressed controls; thus the 
facilitation of escape-avoidance behavior by this dose of P 
was not associated with "supra-normal" levels of ITC. 
(2) According to a cognitive hypothesis, P might have 
facilitated the detection of differences in reinforcement con- 
tingencies between session I (unsignalled and uncontrollable 
shocks) and session II (shocks preceded by a visual signal 
and controllable by escape or avoidance responses). 
(3) The facilitation of escape-avoidance behavior of 
stressed rats by P could be due to a normalizing action of the 
drug on the brain. Uncontrollable and unsignalled shocks 
deplete brain catecholamines and this decrease is perhaps 
the cause of the LH phenomenon [1]. P could restore normal 
levels of catecholamines. There is no direct proof in favor of 
this hypothesis but several data suggest that P may act on 
brain catecholaminergic mechanisms [5, 12, 15, 23]. It may 
also modulate other neurotransmitters through its interaction 
with the two main second-messengers, cAMP and phos- 
photidylinositol [12]. 
Whatever be the nature of this action, these experiments 
confirm that the facilitation of learning by P is more detecta- 
ble in disturbed organisms than in normal ones. Our results 
give also a new and potentially important information: these 
beneficial effects may be significant not only in animals im- 
paired by organic pathologies but also in organically normal 
animals whose behavior is disturbed by environmental fac- 
tors. Thus, the normalizing effects of P could have a much 
larger range than that presently assumed. 
Finally, although it was not within the scope of this series 
of experiments to study the mechanisms of depression, our 
results, as well as those of Schmidt [22], may be suggestive 
in this respect, since the LH phenomenon was used as a 
model of behavioral disturbance. According to the second 
hypothesis considered above, the fact that a nootropic drug 
decrease LH could provide an argument in favor of cognitive 
theories of depression [1]. 
However, this argument is not decisive since the rele- 
vance of LH to depression as well as the relationship be- 
tween the effects of P on learning tasks and a facilitation of 
cognitive abilities remain controversial. 
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